Resistance to neoadjuvant talazoparib in triple-negative breast cancer by BRN2-induced ATR/STAT3 pathways or SHLD2 subclone expansion
BRN2诱导的ATR/STAT3通路或SHLD2亚克隆扩增导致三阴性乳腺癌对新辅助他拉唑帕尼产生耐药性。
期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2513742123
Abdulkareem, Noor M; Jiang, Yan; Qi, Yuan; Liu, Xuan; Zhang, Xiaomei; Cai, Shirong; Shao, Jiansu; Jeter-Jones, Sabrina; Rinkenbaugh, Amanda L; Cheng, Chun-Chun; Hancock, Faiza; Schwartz, Jill; Litton, Jennifer K; Chang, Jeffrey T; Piwnica-Worms, Helen
肿瘤
肿瘤免疫
JAK/STAT
信号转导
乳腺癌
STAT3
ATR